|Science, The Public, and New Policies
Tuesday, November 27, 2001
Rita Colwell , Ph.D.
|STI571: A Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia (CML) Validating the Promise of Molecularly Targeted Therapy
Wednesday, November 7, 2001
Brian Druker, M.D.
|Protein Folds, Functions, and Evolution
Wednesday, October 31, 2001
Janet Thornton, Ph.D.
|Aspects of Pediatric Epilepsy Surgery
Wednesday, October 24, 2001
Benjamin S. Carson, Sr., M.D.
|Translating the Histone Code: A Tale of Tails
Wednesday, October 17, 2001
C. David Allis, Ph.D.
|Regulation of Genome Expression in Living Eukaryotic Cells
Wednesday, September 26, 2001
Richard A. Young, Ph.D.
|Cancer: An Unfortunate Genetic Collaboration
Wednesday, June 27, 2001
Philip Leder, M.D., D.Sc.
|Nicotinic Acetylcholine Receptor and the Structural Basis of Fast Synaptic Transmission
Wednesday, June 20, 2001
Nigel Unwin, Ph.D., FRS, Head, Division of Neurobiology MRC Laboratory for Molecular Biology, Cambridge.
|The Evolution of Drug Resistance in Viral and Bacterial Populations within the Treated Patient and Spread Within the Community
Tuesday, June 19, 2001
Roy Anderson, FRS, Department of Infectious Disease Epidemiology, Imperial College School of Medicine, University of London.
|Structure, Function and Regulation of NhaA, a Key Na+/H+ Antiporter for pH and Na+ Homeostasis
Wednesday, June 13, 2001
Etana Padan, Ph.D., Professor, Division of Microbial and Molecular Ecology, Institute of Life Sciences, The Hebrew University of Jerusalem.